Megan MGN 深 滬
等待開盤 09-17 09:30:00 美东时间
0.1329
+0.004
+3.26%
華盛通- 最 高0.1617
- 今 開0.1606
- 成交量 1.82亿股
- 最 低 0.109
- 昨 收 0.1287
- 總市值 4917.3
- 52周最高 5.18
- 市盈率 靜 2.43
- 換手率 492899.36%
- 52周最低 0.0557
- 委 比 -25.00%
- 總股本 3.70万
- 歷史最高 8.63
- 量 比 2.83
- 振 幅 40.95%
- 歷史最低 0.0557
- 每 手 1
- 風險率 1.17%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Why Tempest Therapeutics Shares Are Trading Higher By Around 50%; Here Are 20 Stocks Moving Premarket
Shares of Tempest Therapeutics Inc (NASDAQ:TPST) rose sharply in pre-market trading after the California-based clinical-stage biotechnology company announced an exclusive option agreement with Hebei Senlang Biotechnology Co., Ltd. According to the announcement, the agreement gives Tempest an exclusi...
09-16 17:04
Dogfish Head Announces Lineup of Fall-Favorite Beverages
Dogfish Head Craft Brewery introduces its fall lineup, featuring seasonal beers and spirits. Highlights include Punkin Ale, a classic pumpkin beer, and the "Pass the Aux" variety pack with four fall-flavored beers. New offerings include XOCOLATL World Wide Stout, a rich Imperial Stout aged with cocoa nibs and spices, and Punkin Liqueur, crafted from Punkin Ale and aged in rum barrels. These seasonal beverages are perfect for autumn celebrations.
09-10 17:43
Entrada Therapeutics Announces Recipients of Fourth Annual DREAMS Grant Program
Entrada Therapeutics announced the recipients of its 2026 DREAMS Grant Program, awarding $50,000 each to Parent Project Muscular Dystrophy (PPMD) in the U.S. and Duchenne Parent Project Netherlands. PPMD will focus on improving access to specialized care for underserved communities, particularly adults and those in rural areas, through multilingual resources and provider education. Duchenne Parent Project Netherlands will expand its early-interve...
09-10 11:00
Megan Holdings Announces 1-For-30 Share Consolidation Effective September 17, Superseding Prior 1-For-40 Plan
As previously disclosed by Megan Holdings Limited (the "Company"), at the Annual General Meeting of Shareholders held on July 13, 2026, the Company’s shareholders approved the consolidation of the Company’s issued and unissued Class A Ordinary Shares and Class B Ordinary Shares at an aggregate ratio...
09-09 21:06
Remitly partners with Etsy to give sellers more choice in how they get paid globally
Remitly partners with Etsy to offer local payment options for new sellers in 15 countries. Starting this fall, Etsy sellers can choose Remitly as their payout provider, enabling them to hold earnings in USD, convert to local currencies, and deposit funds directly to bank accounts or mobile wallets. This marks Remitly's expansion into supporting small and medium businesses globally, building on its trusted cross-border payment network.
09-09 13:00
Cartesian Therapeutics Announces New Employment Inducement Grants
Cartesian Therapeutics granted inducement awards, including stock options, to three new employees on September 4, 2026. The options, totaling 59,700 shares with an exercise price of $9.27, vest over four years and have a ten-year term. The company, focused on cell therapy for autoimmune diseases, is advancing its lead asset, Descartes-08, in multiple clinical trials.
09-08 11:00
Cartesian Therapeutics to Participate in Upcoming Investor Conferences
Cartesian Therapeutics, a late clinical-stage biotechnology company, announced its management will participate in three investor conferences in September 2026. These include a fireside chat at the 2026 Cantor Global Healthcare Conference on September 10, investor meetings at Morgan Stanley’s 24th Annual Healthcare Conference on September 14, and another fireside chat at the H.C. Wainwright 28th Annual Global Investment Conference on September 15....
09-03 11:00
In One Chart | Top Traded US Stocks as of 16:17, Aug. 28th, 2026
U.S. stock futures mixed ahead of Fed Chair Warsh's Jackson Hole speech, with major premarket movers including ESTC +19.4%, WHLR +125.9%, and PYPL -14.5% on failed acquisition talks.
08-28 16:32
Ulta Beauty (ULTA) 2026财年第二季度业绩电话会议：上调销售额及每股收益指引
Ulta Beauty 2026财年第二季度销售额增长8.9%，每股收益增长13.3%；在香水业务领跑增长的带动下，管理层上调了全年销售额和盈利指引。
08-27 23:42
Ulta Beauty (ULTA) Fiscal Q2 2026 Earnings Call: Sales and EPS Guidance Raised
Ulta Beauty fiscal Q2 2026 sales rose 8.9%, EPS gained 13.3%, and management raised full-year sales and earnings guidance as fragrance led growth.
08-27 23:41
